Key result
Frailty links to ~62% higher 30-day MACE risk before adjusting for functional capacity or biomarkers.
Why the study?
The incremental prognostic value of frailty beyond established risk stratification tools, including clinical indices, functional capacity, and biomarkers, remains uncertain.
Does frailty status improve preoperative cardiac risk stratification for 30-day major adverse cardiac events in older adults undergoing noncardiac surgery beyond established clinical indices, functional capacity, and biomarkers?
Cohort
Yes
Does frailty status improve preoperative cardiac risk stratification for 30-day major adverse cardiac events in older adults undergoing noncardiac surgery beyond established clinical indices, functional capacity, and biomarkers?
Odds Ratio: 1.62 (95% CI 1.05–2.51)
Frailty improves preoperative cardiac risk prediction beyond basic clinical factors, but adds no incremental prognostic value when functional capacity (DASI) or natriuretic peptide biomarkers are already available.
Frailty may support selective preoperative risk assessment only when functional capacity or biomarkers unavailable; leaves open incremental value in comprehensive evaluations.
BACKGROUND: Frailty is prevalent among older adults and associated with increased postoperative morbidity and death. Guidelines recommend consideration of frailty to inform preoperative cardiac risk stratification. However, its incremental prognostic value beyond established tools including clinical indices, functional capacity, and biomarkers is uncertain. METHODS: We conducted a secondary analysis of a multicenter prospective cohort study involving older adults (aged ≥65 years) undergoing major elective noncardiac surgery. Frailty was assessed using the Clinical Frailty Scale. The primary outcome was 30-day major adverse cardiac events, defined as myocardial infarction, nonfatal cardiac arrest, or death. Multivariable logistic regression evaluated the association between frailty (Clinical Frailty Scale ≥4) and major adverse cardiac events, adjusting for age, sex, Revised Cardiac Risk Index, Duke Activity Status Index, and natriuretic peptide concentration. Incremental prognostic value was assessed using the likelihood ratio test, concordance index, fraction of new predictive information, and decision curves. RESULTS: =-0.64). Frailty was associated with major adverse cardiac events after adjustment for age, sex, and Revised Cardiac Risk Index (odds ratio, 1.62 [95% CI, 1.05-2.51]) but not after further adjustment for Duke Activity Status Index or natriuretic peptide concentrations. Frailty improved prediction beyond clinical factors alone but not when functional capacity or biomarkers were included. CONCLUSIONS: Frailty was associated with increased cardiac risk and improved prediction beyond clinical factors, but its incremental prognostic value diminished when functional capacity or biomarkers were available, supporting its selective use when these measures are unavailable.
No takes yet. Share an insight, caveat, or question.
Chatziperi et al. (2026) conducted a cohort in Older adults undergoing major elective noncardiac surgery. Frailty (Clinical Frailty Scale ≥4) vs. No frailty was evaluated on 30-day major adverse cardiac events (myocardial infarction, nonfatal cardiac arrest, or death) (OR 1.62, 95% CI 1.05-2.51). Frailty was associated with 30-day major adverse cardiac events after adjusting for clinical factors (OR 1.62; 95% CI 1.05-2.51), but not after adjusting for functional capacity or biomarkers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: